Era-Net (MOH): ERDERA Clinical Trial Call (ECTC) – EOI (stage 0)

Stage 1: short proposal, Stage 2: Support phase, invited Stage 3: Full proposal
To support multinational, GCP‑compliant early‑phase interventional clinical trials in rare diseases.
Priority areas: paediatric rare diseases; rapidly progressive rare diseases; and rare diseases with no approved therapeutic options or with substantial residual unmet medical need despite existing treatments.
* Each consortium must designate a Clinical Trial Sponsor and a Coordinating Investigator, include at least one funded patient partner (via a PAO or other organised patient group), and secure access to a qualified multinational Clinical Trial Management Organisation (CTMO).
Only multinational trials will be funded (minimum of three independent eligible partner institutions from at least three different eligible countries; PAOs focused primarily on PPIE do not count towards this minimum).
https://erdera.org/call/ctc2026/
Information webinar: 6 July 2026, 15:00–17:00 CEST. More information and registration: https://erdera.org/event/erdera-clinical-trial-call-2026-information-webinar/.